Why Amazon, Salesforce, Zoom, and Other Stay-at-Home Stocks Dropped Today
On Monday, investors sold off many stocks that performed well during the early stages of the pandemic, following encouraging news about a new antiviral drug for COVID-19 late last week.
Here's how some of the most popular of these stocks performed today:
On Friday, Merck (NYSE: MRK) shared interim data from a phase 3 study that suggested its experimental oral antiviral treatment could reduce the risk of hospitalization or death by nearly 50% for patients with mild or moderate cases of COVID. The drugmaker said it plans to request Emergency Use Authorization for the drug from the Food and Drug Administration "as soon as possible."
Source Fool.com
